Loading color scheme

Li Wan, PhD, RAC

Vice President, Regulatory Affairs  

Dr. Li Wan has over sixteen years of industry experience in the regulatory affairs and drug development for innovative small molecule and biological product in the oncology, central nervous system (CNS), and ophthalmology area. He is currently the VP of Regulatory Affairs at OncoC4.

Before joining OncoC4, Dr. Li Wan held the positions of Senior VP pf Global Regulatory Affair at GeneQuantum Healthcare, VP of Global Regulatory Affairs at Alphamab Oncology and Luye Pharma. Prior to Luye, he worked in the world-renowned big pharmaceutical companies including Pfizer and Novartis. He has successfully led many global IND/CTA/NDA/BLA submissions and obtained approvals in the US, EU, and China etc. He is a well-known expert in global regulatory affairs and has been an invited speaker at many professional organizations and conferences.

Dr. Wan holds a doctoral degree in Pharmaceutical Science from Rutgers University and is a certified regulatory affair professional by the Regulatory Affairs Professional Society, USA.